Inventor · disambiguated record
David A. Johnson
Also filed as: JOHNSON DAVID · JOHNSON DAVID A · JOHNSON DAVID ADRIAN · SLEEZER PAUL D
59 granted patents·11 pending applications·2,016 citations·filing 1964–2022
99Inventor score
Top patents by PatentIndex Score
70 records- 0198US6113918AAminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectorsRIBI IMMUNOCHEM RESEARCH INC·Filed 1997·Granted Sep 5, 2000·460 cites·84 claims
- 0297US6649172B2Amphipathic aldehydes and their uses as adjuvants and immunoeffectorsCORIXA CORP·Filed 2001·Granted Nov 18, 2003·114 cites·27 claims
- 0397US6303347B1Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectorsCORIXA CORP·Filed 1999·Granted Oct 16, 2001·277 cites·36 claims
- 0496US6525028B1Immunoeffector compoundsCORIXA CORP·Filed 2002·Granted Feb 25, 2003·186 cites·39 claims
- 0595US6911434B2Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compoundsCORIXA CORP·Filed 2002·Granted Jun 28, 2005·92 cites·28 claims
- 0695US6764840B2Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectorsCORIXA CORP·Filed 2001·Granted Jul 20, 2004·128 cites·53 claims
- 0794US8624029B2Lipidated imidazoquinoline derivativesJOHNSON DAVID A·Filed 2009·Granted Jan 7, 2014·14 cites·2 claims
- 0894US7129219B2Immunoeffector compoundsCORIXA CORP·Filed 2001·Granted Oct 31, 2006·59 cites·33 claims
- 0992US6355257B1Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectorsCORIXA CORP·Filed 1998·Granted Mar 12, 2002·119 cites·6 claims
- 1089US10351582B2Pegylated imidazoquinolinesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Jul 16, 2019·3 cites·9 claims
- 1188US5028697ACytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkersLILLY CO ELI·Filed 1988·Granted Jul 2, 1991·54 cites·20 claims
- 1287US8946421B2Lipidated imidazoquinoline derivativesGLAXOSMITHKLINE BIOLOG SA·Filed 2013·Granted Feb 3, 2015·8 cites·6 claims
- 1387US8575340B2Purine derivatives and their pharmaceutical usesBAZIN-LEE HELENE·Filed 2011·Granted Nov 5, 2013·13 cites·7 claims
- 1485US5556847AMethods of effecting memory enhancement mediated by steroid sulfatase inhibitorsUNIV HOLY GHOST DUQUESNE·Filed 1994·Granted Sep 17, 1996·80 cites·45 claims
- 1584US7063967B2Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectorsCORIXA CORP·Filed 2002·Granted Jun 20, 2006·17 cites·13 claims
- 1684US6699846B2Mono- and disaccharides for the treatment of nitric oxide related disordersCORIXA CORP·Filed 2001·Granted Mar 2, 2004·31 cites·35 claims
- 1783US7288640B2Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates thereforCORIXA CORP·Filed 2004·Granted Oct 30, 2007·15 cites·43 claims
- 1883US5427899ATwo-phase acidic aqueous compositionsPOLAROID CORP·Filed 1994·Granted Jun 27, 1995·35 cites·13 claims
- 1982US6800613B2Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compoundsCORIXA CORP·Filed 2001·Granted Oct 5, 2004·22 cites·53 claims
- 2081US10774099B2Phospholipidation of imidazoquinolines and oxoadeninesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Sep 15, 2020·2 cites·11 claims
- 2181US7501399B2Immunoeffector compoundsCORIXA CORP·Filed 2006·Granted Mar 10, 2009·4 cites·27 claims
- 2280US8364570B1Certificate of deposit consolidationUSAA·Filed 2011·Granted Jan 29, 2013·2 cites·20 claims
- 2380US7960522B2Certain aminoalkyl glucosaminide phosphate compounds and their useCORIXA CORP·Filed 2004·Granted Jun 14, 2011·10 cites·11 claims
- 2480US7902159B2Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compoundsCORIXA CORP·Filed 2007·Granted Mar 8, 2011·5 cites·53 claims
- 2580US5338553AProcess of treating water containing effluent from cheese-making operationsNIRO ATOMIZER AS·Filed 1992·Granted Aug 16, 1994·47 cites·10 claims
- 2679US7541020B2Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectorsCORIXA CORP·Filed 2002·Granted Jun 2, 2009·11 cites·48 claims
- 2779US4223135AProduction of cephalosporinsBRISTOL MYERS CO·Filed 1979·Granted Sep 16, 1980·10 cites·20 claims
- 2878US9044481B2Lipidated oxoadenine derivativesJOHNSON DAVID·Filed 2010·Granted Jun 2, 2015·4 cites·12 claims
- 2978US8099349B1Certificate of deposit consolidationJOHNSON DAVID ADRIAN·Filed 2008·Granted Jan 17, 2012·6 cites·21 claims
- 3077US7960523B2Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates thereforCORIXA CORP·Filed 2007·Granted Jun 14, 2011·2 cites·8 claims
- 3177US3932392AProcess for the preparation of 7-aminocephalosporanic acidsBRISTOL MYERS CO·Filed 1974·Granted Jan 13, 1976·12 cites·11 claims
- 3276US7829542B2Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compoundsCORIXA CORP·Filed 2008·Granted Nov 9, 2010·2 cites·17 claims
- 3376US4433135AMethod for the prevention of hydrolysis of polyesterification catalystsAKZONA INC·Filed 1982·Granted Feb 21, 1984·28 cites·8 claims
- 3475US10882876B2Pegylated imidazoquinolines as TLR7 and TLR8 agonistsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted Jan 5, 2021·1 cites·12 claims
- 3575US8318697B2Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compoundsPERSING DAVID H·Filed 2011·Granted Nov 27, 2012·3 cites·13 claims
- 3674US7232900B2Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates thereforCORIXA CORP·Filed 2003·Granted Jun 19, 2007·6 cites·2 claims
- 3770US4322522APolyester/polyether segmented copolymers stabilized against degradation by UV light via copolymerization with analogs of 2,2,6,6-tetramethylpiperidine derivativesAKZONA INC·Filed 1980·Granted Mar 30, 1982·19 cites·7 claims
- 3870US3996236AMethoxymethyl D-6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)penicillanateBRISTOL MYERS CO·Filed 1975·Granted Dec 7, 1976·6 cites·2 claims
- 3970US2022144833A1Imidazoquinoline derivatives and their use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 4070US2022144865A1Imidazoquinoline derivatives and their use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 4170US2022119428A1Phospholipidation of imidazoquinolines and oxoadeninesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 4268US2008119415A1Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compoundsCORIXA CORP·Filed 2007·Application pending·0 cites
- 4367US5763492AMethods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitorsDUGUESNE UNIVERSITY OF THE HOL·Filed 1996·Granted Jun 9, 1998·31 cites·18 claims
- 4466US11248012B2Phospholipidation of imidazoquinolines and oxoadeninesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Feb 15, 2022·0 cites·16 claims
- 4566US8626635B1Certificate of deposit consolidationUSAA·Filed 2012·Granted Jan 7, 2014·0 cites·17 claims
- 4666US4304568AMinimizing ozone fading in dyed polyamides by treating same with substituted piperidine thioureasAKZONA INC·Filed 1980·Granted Dec 8, 1981·11 cites·16 claims
- 4764US4262114ASegmented thermoplastic copolyestersAKZONA INC·Filed 1976·Granted Apr 14, 1981·13 cites·31 claims
- 4861US11274115B2Imidazoquinoline derivatives and their use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Mar 15, 2022·0 cites·23 claims
- 4961US5144012ACytotoxic drug conjugatesLILLY CO ELI·Filed 1991·Granted Sep 1, 1992·26 cites·5 claims
- 5061US4351766AProduction of penicillinsBRISTOL MYERS CO·Filed 1981·Granted Sep 28, 1982·5 cites·8 claims
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David A. Johnson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →